| Assessment of quality and reliability of YouTube videos for patient and physician education on inflammatory myositis M Joshi, K Jagtap, R Gupta, V Agarwal, R Aggarwal, A Goel, L Gupta Clinical Rheumatology 42 (5), 1339-1349, 2023 | 20 | 2023 |
| Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period—a cross-sequential study based on COVAD surveys K Jagtap, R Naveen, J Day, P Sen, B Vaidya, A Nune, E Nikiphorou, ... Rheumatology 62 (12), 3838-3848, 2023 | 17 | 2023 |
| Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys P Sen, N Houshmand, S Moghadam Kia, M Joshi, S Saha, K Jagtap, ... Rheumatology 62 (10), 3291-3301, 2023 | 11 | 2023 |
| Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and-2 surveys P Sen, Z Griger, J Day, M Joshi, A Nune, E Nikiphorou, S Saha, AL Tan, ... Rheumatology 63 (1), 127-139, 2024 | 9 | 2024 |
| Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study B Doskaliuk, N Ravichandran, P Sen, J Day, M Joshi, A Nune, ... Rheumatology international 43 (9), 1651-1664, 2023 | 8 | 2023 |
| Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey R Naveen, DR Thakare, M Kuwana, JD Pauling, J Day, M Joshi, I Parodis, ... Rheumatology international 43 (7), 1265-1275, 2023 | 8 | 2023 |
| Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study SS Ali, P Sen, J Day, M Joshi, A Nune, E Nikiphorou, S Saha, AL Tan, ... Rheumatology 62 (9), e263-e268, 2023 | 6 | 2023 |
| Vaccine hesitancy decreases, long term concerns remain in myositis, rheumatic disease patients: A comparative analysis of the COVAD surveys P Sen, R Naveen, N Houshmand, S Moghadam Kia, M Joshi, S Saha, ... Rheumatology, 2023 | 6 | 2023 |
| Flares of autoimmune rheumatic disease following COVID‐19 infection: Observations from the COVAD study NK Sandhu, N Ravichandraan, A Nune, J Day, P Sen, E Nikiphorou, ... International journal of rheumatic diseases 27 (1), e14961, 2024 | 4 | 2024 |
| COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study L Andreoli, D Lini, K Schreiber, I Parodis, P Sen, N Ravichandran, J Day, ... Rheumatology 63 (5), 1341-1351, 2024 | 3 | 2024 |
| Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study LS Hoff, N Ravichandran, P Sen, J Day, M Joshi, A Nune, E Nikiphorou, ... Rheumatology 64 (2), 597-606, 2025 | 1 | 2025 |
| Type 1 diabetes, COVID‐19 vaccines and short‐term safety: Subgroup analysis from the global COVAD study T Chatterjee, N Ravichandran, N Nair, AE Gracia‐Ramos, B Barman, ... Journal of diabetes investigation 15 (1), 131-138, 2024 | 1 | 2024 |
| Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey S Ahmed, L Gupta, M Kuwana, JD Pauling, J Day, N Ravichandran, ... Rheumatology international 44 (1), 89-97, 2024 | 1 | 2024 |
| Pos0573 Comorbidities, Complex Multimorbidity and Promis Health Outcomes Amongautoimmune Rheumatic Diseases: Data from the Covad Study L Gupta, N Ravichandran, V Venerito, M Dey, P Sen, S Saha, AL Tan, ... Annals of the Rheumatic Diseases 82, 555-556, 2023 | 1 | 2023 |
| INFLAMMAGING IN MUSCLE: THE MISSING LINK BETWEEN SARCOPENIA AND IDIOPATHIC INFLAMMATORY MYOPATHIES K Jagtap, LS Hoff, E Conticini, R Naveen, L Gupta Anti-Aging Eastern Europe 1 (1), 63-72, 2022 | 1 | 2022 |
| Reduced Health-Related Quality of Life in Patients With Systemic Sclerosis: A Cross-Sectional Analysis of PROMIS Global Health Data From the International COVAD-2 e-Survey K Yomono, Y Li, V Maroufy, N Ravichandran, A Yoshida, K Jagtap, ... International journal of rheumatic diseases 28 (2), e70101, 2025 | | 2025 |
| Determinants of physical function, as measured using PROMIS PF-10a, in patients with rheumatoid arthritis: results from the international COVID-19 Vaccination in Autoimmune … SS Ali, C Demetriou, I Parodis, AL Tan, A Edgar Gracia-Ramos, M Joshi, ... Rheumatology Advances in Practice 9 (1), rkae154, 2025 | | 2025 |
| COVID-19 Vaccination-related Delayed Adverse Events Among Patients with Systemic Lupus Erythematosus: Results from the COVAD Study M Fathima, B Doskaliuk, J Lindblom, E Nikiphorou, C Wincup, S Saha, ... ARTHRITIS & RHEUMATOLOGY 75, 241-244, 2023 | | 2023 |
| UNMET NEED IN GERIATRICS–PATIENT VOICE M Joshi, K Jagtap, V Agarwal, L Gupta Anti-Aging Eastern Europe 2 (2), 118-121, 2023 | | 2023 |
| LO-019 Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 vaccination in autoimmune disease (COVAD) study EK Olsson, R Naveen, E Nikiphorou, J Lindblom, S Saha, SS Shaharir, ... Lupus Science & Medicine 10 (Suppl 1), 2023 | | 2023 |
